Company Quick10K Filing
Genesis Financial
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-17
10-K 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-01
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-15
10-Q 2016-09-30 Filed 2016-11-04
10-Q 2016-06-30 Filed 2016-07-25
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-28
10-Q 2015-09-30 Filed 2015-11-09
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-12
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-12
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-03-25
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-20
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-04-13
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-16
10-Q 2010-09-30 Filed 2010-11-10
10-Q 2010-06-30 Filed 2010-09-09
10-Q 2010-03-31 Filed 2010-08-19
10-K 2009-12-31 Filed 2010-08-11
10-Q 2009-09-30 Filed 2010-07-22
10-Q 2009-06-30 Filed 2010-07-22
10-Q 2009-03-31 Filed 2010-07-22
10-K 2008-12-31 Filed 2010-06-08
10-Q 2008-09-30 Filed 2010-05-26
10-Q 2008-06-30 Filed 2010-05-26
10-Q 2008-03-31 Filed 2010-05-26
10-K 2007-12-31 Filed 2010-04-23
8-K 2020-03-24
8-K 2019-10-21
8-K 2018-10-25
8-K 2018-07-27
8-K 2018-05-10
8-K 2018-04-18
8-K 2018-04-01
8-K 2018-02-15
8-K 2018-01-24

Genesis Financial Financials

GFNL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Wize Pharma (WIZP) 3,714 0% -0.9 -123% 2,091 2,238 2 0 -2,577 -2,577 2,229
Encision (ECIA) 3,709 51% -115.6 -4% 4,148 1,933 8,055 4,147 -152 -31 3,568
Geospatial (GSPH) 3,709 70% -6.3 -736% 111 3,656 273 190 -816 -586 3,668
Mentor Capital (MNTR) 3,702 29% -1.0 -59% 5,269 1,972 3,177 930 -3,131 -3,080 2,951
Blake Insomnia Therapeutics (BKIT) 3,681 -135.2 0 237 0 0 -27 -27 3,681
Cartesian (CRTN) 3,632 30% -0.4 -44% 16,522 17,461 47,555 14,053 -7,270 -5,582 2,087
Invesco CurrencyShares Singapore Dollar Trust (FXSG) 3,628 0% -50.4 1% 3,558 1 40 0 26 26 -1,288
Fieldpoint Petroleum (FPP) 3,628 0% 13.8 -5% 4,528 6,259 1,668 0 -241 247 3,414
Immune Pharmaceuticals (IMNP) 3,597 -0.9 -71% 20,716 19,874 0 0 -14,715 -13,953 12,494
American Bio Medica (ABMC) 3,580 35% -28.9 -20% 2,246 2,809 2,776 971 -440 -177 5,119
Empire Petroleum (EMPR) 3,576 0% -3.0 -30% 11,795 13,670 4,941 0 -3,541 -3,815 11,553
Genesis Financial (GFNL) 3,571 0% -1.1 -155% 2,427 3,394 10 0 -3,756 -3,242 3,551
Frontier Oilfield Services (FOSI) 3,542 0% -5.7 -319% 868 11,161 646 0 -2,768 -2,021 11,479
Coretec (CRTG) 3,505 -2.8 -107% 1,424 3,504 0 0 -1,520 -1,229 3,497
Sauer Energy (SENY) 3,496 49% -2.8 -116% 1,092 291 30 15 -1,271 -1,239 3,494
Vycor Medical (VYCO) 3,465 91% -6.4 -53% 1,086 2,353 1,127 1,020 -575 -530 3,367
Puradyn Filter Technologies (PFTI) 3,451 24% -14.2 -47% 2,470 12,620 1,278 303 -1,160 -826 11,763
Igen Networks (IGEN) 3,418 68% -2.6 -137% 604 2,437 594 405 -830 -1,315 3,381
Invesco CurrencyShares Chinese Renminbi Trust (FXCH) 3,414 0% 1,654.7 -0% 3,419 1 4 0 -13 -13 -21,003
Giggles N' Hugs (GIGL) 3,381 0% -17.2 -29% 1,185 3,455 1,931 0 -341 -196 3,378

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash3322345315448124252155568764638085317325151164203530810020
Accounts Receivable
Inventory2,189
PP&E77666555582433119393715772810
Assets4,1453,6693,5984,8124,6885,2465,1774,6684,4354,0623,5873,7343,4143,2583,3803,2941,6001,5231,2681,3341,1851,1289838947242,8792,7472,427
Accounts Payable
Long-Term Debt10
Liabilities1,9991,9121,8811,7211,7111,9121,9601,9321,9951,7881,6211,6561,6731,6971,7811,7941,7239841,1161,1601,1832,5123,1983,394
Stockholders' Equity2,1461,7571,7163,0912,9773,3343,2162,7362,4402,2751,9662,0781,7421,5601,5991,500-12328421726-459367-451-967
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue1934186637534270452062519533642347025818361023610
Cost of Revenue
Gross Profit
R&D
SG&A37422534244126744643994767431237624338
Tax000
Net Income-32-389-41-50-327-34-1719-295135-341-40-353-33-50-105-1,43684-444-99-201-54-166-87-216-1,714-827-999
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating326241-291-815674297-3326134-24-44250-178-53-143206-31-36-36-37-914-306-183
Cash Investing750039020-25397030-5-85-157-38
Cash Financing-35-50-1518545-25-5-195-653614238313-63-170313343-12-7-1145550235161